Research Library
Use the Search Fields to Find Information
Found 690 Results
Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
Fragile X syndrome, the most commonly known genetic cause of autism, is due to loss of the fragile X mental retardation protein, which regulates signal transduction at metabotropic glutamate receptor-5 in the brain. Fragile X mental retardation protein deletion in mice enhances metabotropic glutamate receptor-5-dependent long-term depression in the hippocampus and cerebellum. Here we show […]
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
BACKGROUND The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug-resistant seizures and a high mortality rate. We studied cannabidiol for the treatment of drug-resistant seizures in the Dravet syndrome. METHODS In this double-blind, placebo-controlled trial, we randomly assigned 120 children and young adults with the Dravet syndrome and drug-resistant seizures […]
Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
Hypercholesterolemia is one of the most important risk factors for erectile dysfunction, mostly due to the impairment of oxidative stress and endothelial function in the penis. The cannabinoid system might regulate peripheral mechanisms of sexual function; however, its role is still poorly understood. We investigated the effects of CB2 activation on oxidative stress and fibrosis […]
Treatment of Tourette-Syndrome with ∆ 9 -Tetrahydrocannabinol (THC): a randomized crossover trial
Anecdotal reports in Tourette-Syndrome (TS) suggested that marijuana (cannabis sativa) and delta-9-Tetrahydrocannabinol (∆ 9 -THC), the major psychoactive ingredient of marijuana, reduce tics and associated behavioral disorders. We performed a randomized double-blind placebo-controlled crossover singledose trial of ∆ 9 -THC (5.0, 7.5 or 10.0 mg) in 12 adult TS patients. Tic severity was assessed using […]
Treatment of Tourette syndrome with cannabinoids
Cannabinoids have been used for hundred of years for medical purposes. To day, the cannabinoid delta-9- tetrahydrocannabinol (THC) and the cannabis extract nabiximols are approved for the treatment of nausea, anorexia and spasticity, respectively. In Tourette syndrome (TS) several anecdotal reports provided evidence that marijuana might be effective not only in the suppression of tics, […]
Treatment of Crohn’s disease with cannabis: an observational study.
BACKGROUND: The marijuana plant cannabis is known to have therapeutic effects, including improvement of inflammatory processes. However, no report of patients using cannabis for Crohn’s disease (CD) was ever published. OBJECTIVES: To describe the effects of cannabis use in patients suffering from CD. METHODS: In this retrospective observational study we examined disease activity, use of […]
Traumatic brain injury; Endocannabinoids; Neuroprotection; BBB integrity; Inflammation; Cytokines; Reactive oxygen species
The Cannabis sativa plant has been exploited for medicinal, agricultural and spiritual purposes in diverse cultures over thousands of years. Cannabis has been used recreationally for its psychotropic properties, while effects such as stimulation of appetite, analgesia and anti-emesis have lead to the medicinal application of cannabis. Indeed, reports of medicinal efficacy of cannabis can […]
Towards the use of cannabinoids as antitumour agents
Various reports have shown that cannabinoids (the active components of marijuana and their derivatives) can reduce tumour growth and progression in animal models of cancer, in addition to their well-known palliative effects on some cancer-associated symptoms. This Opinion article discusses our current understanding of cannabinoids as antitumour agents, focusing on recent insights into the molecular […]
Toward Drugs Derived from Cannabis
Recent work aimed at the introduction of natural and synthetic cannabinoids as drugs is reviewed. A 1_ Tetrahydrocannabinol (A1-THC) is mainly investigated as a potential drug against glaucoma and asthma, and as an antiemetic agent in cancer chemotherapy. Cannabidiol is being tried in the clinic against epilepsy and as a hypnotic. Numerous synthetic cannabinoids are […]